Original-Research: Smartbroker Holding AG - von GBC AG Einstufung von GBC AG zu Smartbroker Holding AG Unternehmen: Smartbroker Holding AG ISIN: DE000A2GS609 Anlass der Studie: Research study
Einstufung von GBC AG zu Smartbroker Holding AGEmpfehlung: BUYFY 2022 closed with robust revenue performance and Smartbroker realignment; Positive operating revenue and earnings development also expected for current FY 2023; The strong expansion of the platform-based transaction business should in future provide for a dynamic turnover and earnings development provide; Target price: EUR 17.
At the earnings level, the operating EBITDA rose disproportionately to the development of turnover by 146.3% to EUR 8.77 million . The dynamic improvement in earnings is essentially based on significantly-reduced customer acquisition costs for the Smartbroker, which resulted from the planned restructuring of the Smartbroker 2.0 setup. Adjusted for new customer acquisition costs for the Smartbroker, which amounted to EUR 4.02 million , an adjusted EBITDA of EUR 12.79 million was achieved.
In the context of the publication of our research study on the preliminary annual results of Smartbroker's 2022 financial year, we have adjusted our previous revenue and earnings estimates downwards for the current financial year and also for the following years. In view of the reaffirmed positive corporate guidance, we also confirm our previous revenue and earnings forecasts for the current financial year and subsequent years.
Italia Ultime Notizie, Italia Notizie
Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.
Original-Research: Aspermont Ltd (von GBC AG): KaufenOriginal-Research: Aspermont Ltd - von GBC AG Einstufung von GBC AG zu Aspermont Ltd Unternehmen: Aspermont Ltd ISIN: AU000000ASP3 Anlass der Studie: Research Update Empfehlung: Kaufen Kursziel:
Leggi di più »
Original-Research: Aspermont Ltd (von GBC AG): BuyOriginal-Research: Aspermont Ltd - von GBC AG Einstufung von GBC AG zu Aspermont Ltd Unternehmen: Aspermont Ltd ISIN: AU000000ASP3 Anlass der Studie: Research Update Empfehlung: Buy Kursziel:
Leggi di più »
Original-Research: Health Italia S.p.A. (von GBC AG): BUYOriginal-Research: Health Italia S.p.A. - von GBC AG Einstufung von GBC AG zu Health Italia S.p.A. Unternehmen: Health Italia S.p.A. ISIN: IT0005221004 Anlass der Studie: Research Report (Initiating
Leggi di più »
EQS-CMS: Daimler Truck Holding AG: Veröffentlichung einer KapitalmarktinformationEQS Zulassungsfolgepflichtmitteilung: Daimler Truck Holding AG / Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014 i.V.m. Art. 2 Abs. 3 der
Leggi di più »